Abstract Treatment outcomes for major depressive disorder (MDD) need to be improved.
Presently, no clinically relevant tools have been established for stratifying subgroups or …

Although anxiety and depression have been considered as two distinct entities according to
the diagnostic criteria, anxious depression (comorbid anxiety and depression) is relatively a …

Although monoaminergic antidepressants revolutionized the treatment of Major Depressive
Disorder (MDD) over a half-century ago, approximately one third of depressed patients …

Side effects to antidepressant medications are common and can impact the prognosis of
successful treatment outcome in people with major depressive disorder (MDD). However …

Anxious depression appears to be a common and clinically relevant subtype of depression
as it predicts poorer course trajectories. As populations with anxious depression may benefit …

Background Retirees face numerous challenges, including disassociation from persons in
their social networks in Nigeria. Perceived social isolation or loneliness could impair the …

Очередное, четвертое издание монографии, посвященной проблеме депрессий. В
книге, выполненной через 11 лет после выхода в свет в 2003 г. предыдущего издания …

Objective Patents with anxious bipolar disorder have worse clinical outcomes and are
harder to treat with traditional medication regimens compared to those with non‐anxious …

(1) Background: While the therapeutic efficacy of Transcranial Magnetic Stimulation (TMS)
for major depressive disorder (MDD) is well established, less is known about the technique's …

Background Anxious depression is one of the common subtypes of major depressive
disorder (MDD). Clinically, patients with anxious depression exhibit more severe depressive …